Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Hutchmed

Clinical trials sponsored by Hutchmed, explained in plain language.

HUTCHMED HCM NASDAQ

Biopharmaceutical company developing cancer and immunology therapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 3 Completed 6 Terminated 3

Can a new drug shrink Hard-to-Treat solid tumors?

Disease control Not yet recruiting

This trial tests an experimental drug called HMPL-A830 in adults with advanced solid tumors that have not responded to standard treatments. The study has two parts: first, finding a safe dose, then testing that dose in more people to see if it can shrink tumors. The goal is to un…

Phase: PHASE1, PHASE2 • Sponsor: Hutchmed • Aim: Disease control

Last updated Jul 24, 2026 00:00 UTC